Denali Therapeutics Inc. Quarterly Nonoperating Income (Expense) in USD from Q1 2017 to Q4 2023

Taxonomy & unit
us-gaap: USD
Description
The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).
Summary
Denali Therapeutics Inc. quarterly/annual Nonoperating Income (Expense) history and growth rate from Q1 2017 to Q4 2023.
  • Denali Therapeutics Inc. Nonoperating Income (Expense) for the quarter ending December 31, 2023 was $13.1M, a 97.1% increase year-over-year.
  • Denali Therapeutics Inc. Nonoperating Income (Expense) for the twelve months ending December 31, 2023 was $51.5M, a 249% increase year-over-year.
  • Denali Therapeutics Inc. annual Nonoperating Income (Expense) for 2023 was $51.5M, a 249% increase from 2022.
  • Denali Therapeutics Inc. annual Nonoperating Income (Expense) for 2022 was $14.8M, a 222% increase from 2021.
  • Denali Therapeutics Inc. annual Nonoperating Income (Expense) for 2021 was $4.6M, a 50.3% decline from 2020.
Nonoperating Income (Expense), Trailing 12 Months (USD)
Nonoperating Income (Expense), Quarterly (USD)
Nonoperating Income (Expense), YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q4 2023 $51.5M $13.1M +$6.47M +97.1% Oct 1, 2023 Dec 31, 2023 10-K 2024-02-28
Q3 2023 $45M $14.4M +$10.3M +245% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-07
Q2 2023 $34.8M $12.9M +$10.3M +387% Apr 1, 2023 Jun 30, 2023 10-Q 2023-08-08
Q1 2023 $24.5M $11M +$9.76M +763% Jan 1, 2023 Mar 31, 2023 10-Q 2023-05-08
Q4 2022 $14.8M $6.66M +$5.38M +418% Oct 1, 2022 Dec 31, 2022 10-K 2024-02-28
Q3 2022 $9.4M $4.19M +$3.18M +317% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-07
Q2 2022 $6.22M $2.65M +$1.52M +135% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-08
Q1 2022 $4.69M $1.28M +$99K +8.4% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-08
Q4 2021 $4.6M $1.29M -$345K -21.2% Oct 1, 2021 Dec 31, 2021 10-K 2024-02-28
Q3 2021 $4.94M $1.01M -$939K -48.3% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-03
Q2 2021 $5.88M $1.13M -$1.47M -56.7% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-08
Q1 2021 $7.35M $1.18M -$1.89M -61.6% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-05
Q4 2020 $9.24M $1.63M -$2.18M -57.2% Oct 1, 2020 Dec 31, 2020 10-K 2023-02-27
Q3 2020 $11.4M $1.94M -$1.84M -48.6% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-04
Q2 2020 $13.3M $2.6M -$1.52M -36.8% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-04
Q1 2020 $14.8M $3.07M -$447K -12.7% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-05
Q4 2019 $15.2M $3.81M +$997K +35.5% Oct 1, 2019 Dec 31, 2019 10-K 2022-02-28
Q3 2019 $14.2M $3.78M +$1.19M +45.9% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-05
Q2 2019 $13M $4.11M +$1.46M +54.7% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-07
Q1 2019 $11.6M $3.52M +$1.45M +69.9% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-07
Q4 2018 $10.1M $2.81M +$2.16M +330% Oct 1, 2018 Dec 31, 2018 10-K 2021-02-26
Q3 2018 $7.97M $2.59M +$2.15M +484% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-06
Q2 2018 $5.83M $2.66M +$2.22M +512% Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-06
Q1 2018 $3.6M $2.07M +$1.65M +388% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-08
Q4 2017 $1.96M $653K Oct 1, 2017 Dec 31, 2017 10-K 2020-02-27
Q3 2017 $444K Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-08
Q2 2017 $434K Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-09
Q1 2017 $424K Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-11
* An asterisk sign (*) next to the value indicates that the value is likely invalid.